Tenaya Therapeutics, Inc. Variable Lease, Cost
Tenaya Therapeutics, Inc. (TNYA) reported Variable Lease, Cost of $296.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- Tenaya Therapeutics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $296.00K, a 11.70% increase year-over-year.
- Tenaya Therapeutics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $388.00K, a 5.43% increase year-over-year.
- Tenaya Therapeutics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $380.00K, a 0.80% increase year-over-year.
- Tenaya Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $410.00K, a 8.75% increase year-over-year.
- Tenaya Therapeutics, Inc. variable lease, cost for fiscal 2025 was $1.42M, a 2.27% decline from fiscal 2024.
- Tenaya Therapeutics, Inc. variable lease, cost for fiscal 2024 was $1.46M, a 15.10% increase from fiscal 2023.
- Tenaya Therapeutics, Inc. variable lease, cost for fiscal 2023 was $1.26M, a 4.63% increase from fiscal 2022.
- Tenaya Therapeutics, Inc. variable lease, cost for fiscal 2022 was $1.21M, a 10.41% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $296.00K 10-Q · filed 2026-08-05 | $685.00K 10-Q · filed 2026-08-05 | $1.06M derived: sum of 3 quarters · filed 2026-08-05 | $1.47M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $388.00K 10-Q · filed 2026-05-06 | $768.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.18M derived: sum of 3 quarters · filed 2026-05-06 | $1.44M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $380.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $790.00K derived: sum of 2 quarters · filed 2026-03-11 | $1.05M derived: sum of 3 quarters · filed 2026-08-05 | $1.42M 10-K · filed 2026-03-11 | ||||
| 2025-09-30 | $410.00K 10-Q · filed 2025-11-10 | $675.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.04M 10-Q · filed 2025-11-10 | $1.42M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $265.00K 10-Q · filed 2026-08-05 | $633.00K 10-Q · filed 2026-08-05 | $1.01M derived: sum of 3 quarters · filed 2026-08-05 | $1.39M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $368.00K 10-Q · filed 2026-05-06 | $745.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.12M derived: sum of 3 quarters · filed 2026-05-06 | $1.46M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $754.00K derived: sum of 2 quarters · filed 2026-03-11 | $1.09M derived: sum of 3 quarters · filed 2026-03-11 | $1.46M 10-K · filed 2026-03-11 | ||||
| 2024-09-30 | $377.00K 10-Q · filed 2025-11-10 | $713.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.08M 10-Q · filed 2025-11-10 | $1.43M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $336.00K 10-Q · filed 2025-08-06 | $703.00K 10-Q · filed 2025-08-06 | $1.05M derived: sum of 3 quarters · filed 2025-08-06 | $1.37M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $367.00K 10-Q · filed 2025-05-07 | $713.00K derived: sum of 2 quarters · filed 2025-05-07 | $1.04M derived: sum of 3 quarters · filed 2025-05-07 | $1.36M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $670.00K derived: sum of 2 quarters · filed 2025-03-10 | $992.00K derived: sum of 3 quarters · filed 2025-03-10 | $1.26M 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $324.00K 10-Q · filed 2024-11-06 | $646.00K derived: sum of 2 quarters · filed 2024-11-06 | $919.00K 10-Q · filed 2024-11-06 | $1.22M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $322.00K 10-Q · filed 2024-08-08 | $595.00K 10-Q · filed 2024-08-08 | $894.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.21M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $273.00K 10-Q · filed 2024-05-14 | $572.00K derived: sum of 2 quarters · filed 2024-05-14 | $891.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.24M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $618.00K derived: sum of 2 quarters · filed 2024-03-18 | $971.00K derived: sum of 3 quarters · filed 2024-03-18 | $1.21M 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | $319.00K 10-Q · filed 2023-11-08 | $672.00K derived: sum of 2 quarters · filed 2023-11-08 | $910.00K 10-Q · filed 2023-11-08 | $1.21M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $353.00K 10-Q · filed 2023-08-09 | $591.00K 10-Q · filed 2023-08-09 | $890.00K derived: sum of 3 quarters · filed 2023-08-09 | $1.20M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $238.00K 10-Q · filed 2023-05-10 | $300.00K 10-Q · filed 2022-05-11 | $537.00K derived: sum of 2 quarters · filed 2023-05-10 | $843.00K derived: sum of 3 quarters · filed 2023-05-10 | $1.11M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $605.00K derived: sum of 2 quarters · filed 2023-03-08 | $874.00K derived: sum of 3 quarters · filed 2023-03-08 | $1.09M 10-K · filed 2023-03-08 | $1.60M 10-K · filed 2022-03-23 | |||
| 2021-09-30 | $306.00K 10-Q · filed 2022-11-10 | $400.00K 10-Q · filed 2021-11-10 | $575.00K derived: sum of 2 quarters · filed 2022-11-10 | $796.00K 10-Q · filed 2022-11-10 | $1.20M 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $269.00K 10-Q · filed 2022-08-10 | $400.00K 10-Q · filed 2021-09-08 | $490.00K 10-Q · filed 2022-08-10 | $800.00K 10-Q · filed 2021-09-08 | ||||
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |